gatifloxacin has been researched along with tricalcium phosphate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, A; Oyane, A; Uchida, M; Yokoyama, Y | 1 |
| Ito, A; Matsuno, T; Miyai, T; Nakamura, C; Satoh, T; Sogo, Y; Tamazawa, G; Yamazaki, A | 1 |
| Ito, A; Kimishima, K; Kitahara, K; Matsuno, T; Miyai, T; Satoh, T; Sogo, Y; Tamazawa, G | 1 |
| Ito, A; Kimishima, K; Makiishi, J; Matsuno, T; Satoh, T; Sogo, Y; Tamazawa, G | 1 |
4 other study(ies) available for gatifloxacin and tricalcium phosphate
| Article | Year |
|---|---|
The formation of an antibacterial agent-apatite composite coating on a polymer surface using a metastable calcium phosphate solution.
Topics: Anti-Bacterial Agents; Apatites; Biocompatible Materials; Bone Substitutes; Calcium; Calcium Compounds; Calcium Phosphates; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Gatifloxacin; Ions; Kinetics; Lactoferrin; Materials Testing; Microscopy, Electron, Scanning; Phosphates; Polymers; Solutions; Spectrometry, X-Ray Emission; Staphylococcus aureus; Tetracycline; Time Factors | 2006 |
Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Fluoroquinolones; Gatifloxacin; Male; Osteomyelitis; Polyesters; Porosity; Rabbits | 2008 |
Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Bacteriological Techniques; Bacteroides fragilis; Bacteroides Infections; Biocompatible Materials; Calcium Phosphates; Debridement; Delayed-Action Preparations; Drug Carriers; Fluoroquinolones; Gatifloxacin; Lactic Acid; Mandibular Diseases; Materials Testing; Osteogenesis; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Streptococcal Infections; Streptococcus milleri Group; Tissue Distribution; Tissue Scaffolds | 2011 |
Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Biocompatible Materials; Calcium Phosphates; Chromatography, High Pressure Liquid; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Mandible; Osteogenesis; Osteomyelitis; Polyesters; Rabbits; Streptococcus milleri Group | 2016 |